U-46619

Suppliers

Names

[ CAS No. ]:
56985-40-1

[ Name ]:
U-46619

[Synonym ]:
5-Heptenoic acid, 7-[(1R,4S,5S,6R)-6-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-oxabicyclo[2.2.1]hept-5-yl]-, (5Z)-
(5Z)-7-{(1R,4S,5S,6R)-6-[(1E,3S)-3-Hydroxy-1-octen-1-yl]-2-oxabicyclo[2.2.1]hept-5-yl}-5-heptenoic acid
MFCD00135238
U 46619,(5Z)-7-[(1R,4S,5S,6R)-6-[(1E,3S)-3-Hydroxy-1-octenyl]-2-oxabicyclo[2.2.1]hept-5-yl]-5-heptenoicacid

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
519.7±30.0 °C at 760 mmHg

[ Molecular Formula ]:
C21H34O4

[ Molecular Weight ]:
350.492

[ Flash Point ]:
176.1±18.1 °C

[ Exact Mass ]:
350.245697

[ PSA ]:
66.76000

[ LogP ]:
3.90

[ Vapour Pressure ]:
0.0±3.1 mmHg at 25°C

[ Index of Refraction ]:
1.548

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MJ9681090
CHEMICAL NAME :
5-Heptenoic acid, 7-(6-(3-hydroxy-1-octenyl)-2-oxabicyclo(2.2.1)hept-5- yl)-, (1R-(1-alpha, 4-alpha,5-beta(Z),6-alpha(1E,3S*)))-
CAS REGISTRY NUMBER :
56985-40-1
LAST UPDATED :
198306
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C21-H34-O4

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
66 ug/kg
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - other changes
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 224,369,1983

Safety Information

[ Symbol ]:

GHS02, GHS07

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H225-H319-H336

[ Supplemental HS ]:
Repeated exposure may cause skin dryness or cracking.

[ Precautionary Statements ]:
P210-P280-P304 + P340 + P312-P305 + P351 + P338-P337 + P313-P403 + P235

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
F;Xi

[ Risk Phrases ]:
R11;R36;R66;R67

[ Safety Phrases ]:
S16;S26

[ RIDADR ]:
UN 1231 3/PG 2

Articles

P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.

Thromb. Haemost. 112(1) , 142-50, (2014)

ATP released by activated platelets can serve as a positive feedback machinery to amplify platelet responses by activating P2X1 receptors. It has, however, not been defined how P2X1 activities influen...

Thromboxane A(2) receptor stimulation promotes closure of the rat ductus arteriosus through enhancing neointima formation.

PLoS ONE 9(4) , e94895, (2014)

Ductus arteriosus (DA) closure follows constriction and remodeling of the entire vessel wall. Patent ductus arteriosus occurs when the DA does not close after birth, and this condition is currently tr...

A platelet P-selectin test predicts adverse cardiovascular events in patients with acute coronary syndromes treated with aspirin and clopidogrel.

Platelets 25(8) , 612-8, (2014)

There is wide variation in response to antiplatelet therapy and high on-treatment platelet reactivity is associated with adverse cardiovascular events. The objective here was to determine whether the ...


More Articles

Related Compounds

  • 5-TRANS U-46619
  • U-104
  • U 19451A
  • U-69593
  • U 99194
  • U-62066
  • Piperidine-3-Carboximidamide
  • 4-((Benzyloxy)methyl)benzaldehyde
  • 3-ethyl-6-methoxy-N-pentan-3-ylpyrazin-2-amine
  • 4-Amino-6-methoxy-7-(2-pyrrolidin-1-ylethoxy)quinazoline
  • (R,S,R,S)-Nebivolol
  • 3-(Methyl(2-methylbenzyl)amino)propanamide
  • I+/--(2-Methylphenyl)-2-furanmethanol
  • N-(4-Cyclohexylphenyl)-4-methyl-N-(4-methylphenyl)benzenamine
  • 4-phenoxy-1H-pyrazole
  • 2-(Methylthio)-4H-thieno[3,2-b]pyrrole-5-carboxylic acid